DM002

DM002 · Xadcera Biopharmaceutical (Suzhou) Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DM002, covering 2026-01-15 to 2026-01-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study of DM002 in Patients With Advanced Solid Tumors [Phase 1]